Beth E. Dunning
City of Hope(US)
Publications by Year
Research Areas
Neuropeptides and Animal Physiology, Diabetes Treatment and Management, Pancreatic function and diabetes, Cardiovascular, Neuropeptides, and Oxidative Stress Research, Receptor Mechanisms and Signaling
Most-Cited Works
- → 1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties(2003)612 cited
- → The Role of α-Cell Dysregulation in Fasting and Postprandial Hyperglycemia in Type 2 Diabetes and Therapeutic Implications(2007)366 cited
- → Vildagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Model-Assessed β-Cell Function in Patients with Type 2 Diabetes(2005)362 cited
- → Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes(2006)334 cited
- → Alpha cell function in health and disease: influence of glucagon-like peptide-1(2005)268 cited
- → The Dipeptidyl Peptidase IV Inhibitor Vildagliptin Suppresses Endogenous Glucose Production and Enhances Islet Function after Single-Dose Administration in Type 2 Diabetic Patients(2007)242 cited
- → Effects of Dipeptidyl Peptidase-4 Inhibition on Gastrointestinal Function, Meal Appearance, and Glucose Metabolism in Type 2 Diabetes(2007)200 cited
- → Vildagliptin Enhances Islet Responsiveness to Both Hyper- and Hypoglycemia in Patients with Type 2 Diabetes(2009)182 cited
- → Galanin: a novel pancreatic neuropeptide(1986)178 cited
- → Mechanisms of action of the dipeptidyl peptidase‐4 inhibitor vildagliptin in humans(2011)167 cited